News
Emergent BioSolutions Inc. EBS has acquired exclusive worldwide rights to Chimerix, Inc.’s CMRX smallpox oral antiviral product, Tembexa. The product is the first FDA-approved smallpox oral ...
LONDON and NEW YORK, Sept. 19, 2019 /PRNewswire/ -- EBS, a leading provider of electronic trading platforms and technology services in foreign exc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback